Ticker
PACBCompany Name
PACIFIC BIOSCIENCES OF CALIFORNIA INCSector
HealthcareIndustry
Medical DevicesExchange
NASDAQDate | Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | EBITDA per Share | Share Factor | Weighted Average Shares |
---|---|---|---|---|
6/30/2025 | $ -112.13M | $ -0.37 | 1 | 300.16M |
3/31/2025 | $ -232.04M | $ -0.78 | 1 | 296.86M |
12/31/2024 | $ -242.77M | $ -0.88 | 1 | 274.49M |
9/30/2024 | $ -326.63M | $ -1.2 | 1 | 272.92M |
6/30/2024 | $ -354.07M | $ -1.3 | 1 | 272.38M |
3/31/2024 | $ -260M | $ -0.96 | 1 | 269.58M |
12/31/2023 | $ -277.28M | $ -1.09 | 1 | 253.63M |
9/30/2023 | $ -286.01M | $ -1.12 | 1 | 255M |
6/30/2023 | $ -286.47M | $ -1.15 | 1 | 250.07M |
3/31/2023 | $ -288.5M | $ -1.19 | 1 | 242.03M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
EBITDA / (Shares WA * Share Factor)
(=) EBITDAPS
EBITDAPS for PACIFIC BIOSCIENCES OF CALIFORNIA INC is calculated as follows: EBITDA [ $ -35.21M ] / (Shares WA [ 166.86M ] * Share Factor [ 1 ])
(=) EBITDAPS [ $ -0.21 ]
Minimum
Jun 30, 2024
Maximum
Dec 31, 2020
Average
Median
filtered constituents | 3.78K |
---|---|
min | $ -10.86 |
max | $ 13.95 |
average | $ 2.01 |
median | $ 0.99 |
std | $ 4.26 |